Seroprevalence of anti–SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia

Nega Assefa, Lemma Demissie, Zelalem Teklemariam, Joseph Oundo, Lola Madrid, Addisu Kebede, Yadeta Dessie, J. Anthony G. Scott
doi: https://doi.org/10.1101/2021.06.17.21257323

Article Information

doi 
https://doi.org/10.1101/2021.06.17.21257323
History 
  • June 21, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Nega Assefa1,2,*,
  2. Lemma Demissie1,
  3. Zelalem Teklemariam1,
  4. Joseph Oundo2,
  5. Lola Madrid2,
  6. Addisu Kebede3,
  7. Yadeta Dessie1 and
  8. J. Anthony G. Scott2
  1. 1College of Health and Medical Sciences, Haramaya University, Ethiopia
  2. 2London School of Hygiene & Tropical Medicine, UK
  3. 3Ethiopian Public Health Institute, Addis Ababa, Ethiopia
  1. ↵*corresponding author Nega Assefa, Email: negaassefa{at}yahoo.com
Back to top
Posted June 21, 2021.
Download PDF
Data/Code
Email
Seroprevalence of anti–SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia
Nega Assefa, Lemma Demissie, Zelalem Teklemariam, Joseph Oundo, Lola Madrid, Addisu Kebede, Yadeta Dessie, J. Anthony G. Scott
medRxiv 2021.06.17.21257323; doi: https://doi.org/10.1101/2021.06.17.21257323
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area